<ѻýҕl>Experts Want FDA to Do More to Ensure Food Safetyѻýҕl> New food ingredients are a "complete black box," one expert says Sep 09, 2024
<ѻýҕl>FDA Reviewers Voice Concerns Over Novel UTI Treatmentѻýҕl> Oral antibiotic has potential for inappropriate use, agency says Sep 06, 2024
<ѻýҕl>Diversity Action Plans for Clinical Trials: Evaluating FDA's Draft Guidanceѻýҕl> A critical analysis reveals opportunities and challenges prior to finalization Sep 06, 2024
<ѻýҕl>Nurse Goes Missing; Mpox on Airplanes; Warning on Pain Supplementsѻýҕl> Health news and commentary gathered by ѻýҕl staff Sep 06, 2024
<ѻýҕl>Teen Vaping Hits 10-Year Low in the U.S.ѻýҕl> Rate fell to under 6% this year, down from 7.7% in 2023 Sep 05, 2024
<ѻýҕl>Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delaysѻýҕl> AP finds inspections are lacking nationally and abroad Sep 05, 2024
<ѻýҕl>What to Know About Delta-8 and Other Common Vape Shop Drugsѻýҕl> These substances are often sold through legal loopholes Sep 04, 2024
<ѻýҕl>Neffy Is About to Hit Shelves: Considerations for Prescribingѻýҕl> The first needle-free epinephrine option is encouraging, but we must proceed with caution Sep 03, 2024
<ѻýҕl>FDA OKs Updated Novavax COVID Shotѻýҕl> Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain Sep 03, 2024
<ѻýҕl>Is 'Wellness' Bad News for Healthcare?ѻýҕl> The growing industry is a double-edged sword Sep 02, 2024
<ѻýҕl>If Alzheimer's Drug Ads Had More Data, Here's What Might Happenѻýҕl> A slippery slope: emphasizing side effects could inhibit some people from accepting medicines Aug 30, 2024
<ѻýҕl>Amid Global Emergency, FDA OKs Another Vaccine for Mpoxѻýҕl> "All effective tools" are needed to combat mpox threat, expert says Aug 30, 2024
<ѻýҕl>FDA Releases Final Rule on ID Checks for Tobacco Salesѻýҕl> Retailers will soon have to check IDs of any tobacco product customers thought to be under 30 Aug 29, 2024
<ѻýҕl>Congresswomen Press FDA on Delayed Proposal to Ban Hair-Straightening Chemicalsѻýҕl> Agency has delayed the target date twice Aug 29, 2024
<ѻýҕl>FDA Could Soon Limit Use of Only Drug for COVID Preventionѻýҕl> Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns Aug 27, 2024
<ѻýҕl>Ultraprocessed Foods Are Everywhere. How Bad Are They?ѻýҕl> These foods make up about 60% of Americans' diets Aug 27, 2024
<ѻýҕl>FDA Clears First Automated Insulin-Delivery Tech for Type 2 Diabetesѻýҕl> SmartAdjust technology is used in Insulet's Omnipod 5 Automated Insulin Delivery System Aug 27, 2024
<ѻýҕl>FDA OKs Updated COVID Vaccinesѻýҕl> mRNA vaccines for 2024-2025 season will target the KP.2 subvariant Aug 22, 2024
<ѻýҕl>Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancerѻýҕl> Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib Aug 20, 2024
<ѻýҕl>FDA OKs First Syphilis Screening Test for At-Home Useѻýҕl> Amid a surge in cases, FDA hopes at-home tests will help increase syphilis diagnosis, treatment Aug 16, 2024
<ѻýҕl>FDA Expands Durvalumab Label to Operable Lung Cancerѻýҕl> PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery Aug 16, 2024
<ѻýҕl>FDA to Challenge Food Industry to Take Up New Sodium Targetsѻýҕl> Agency hopes mean intake will drop to approximately 2,750 mg/day if companies comply Aug 15, 2024
<ѻýҕl>Novel Agent for Chronic GVHD Wins FDA Approvalѻýҕl> Axatilimab achieved a 75% response rate in patients with previously treated chronic GVHD Aug 14, 2024
<ѻýҕl>FDA OKs New Option for Primary Biliary Cholangitisѻýҕl> Seladelpar improved biochemical response, ALP normalization versus placebo in phase III trial Aug 14, 2024
<ѻýҕl>Blood Test for Colon Cancer: Panacea or Hype?ѻýҕl> This newly approved testing modality brings challenges and opportunities Aug 14, 2024
<ѻýҕl>IL-31 Drug for Itchy Nodular Skin Disease Gets Thumbs Up From FDAѻýҕl> Nemolizumab significantly improved itch, nodules, and sleep disturbance at 16 weeks Aug 13, 2024
<ѻýҕl>FDA OKs Once-Daily Injection for Hypoparathyroidismѻýҕl> Palopegteriparatide will be the only drug targeting underlying cause of rare endocrine disorder Aug 12, 2024
<ѻýҕl>FDA Rejects MDMA-Assisted Therapy for PTSDѻýҕl> Decision largely expected after agency advisors voted against psychedelic's safety and efficacy Aug 09, 2024
<ѻýҕl>FDA Approves First Emergency Allergy Nasal Sprayѻýҕl> Neffy is a non-needle-based epinephrine treatment for anaphylaxis and other allergic reactions Aug 09, 2024
<ѻýҕl>New Extended-Release Parkinson's Drug Approvedѻýҕl> Novel levodopa and carbidopa formulation led to more time without troublesome dyskinesia Aug 08, 2024
<ѻýҕl>FDA Approves Nalmefene Auto-Injector for Opioid Overdoseѻýҕl> Opioid antagonist previously approved in injectable and nasal spray formulations Aug 08, 2024
<ѻýҕl>IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCLѻýҕl> New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
<ѻýҕl>After Baby's Death, Parents Sue Infant Formula Maker at Center of 2022 Crisisѻýҕl> Lawsuits accuse Abbott of negligence, fraud, and failing to warn parents Aug 08, 2024
<ѻýҕl>FDA OKs Complement Inhibitor for IgA Nephropathyѻýҕl> First-in-class iptacopan approved to reduce proteinuria in adults with rare progressive disease Aug 08, 2024
<ѻýҕl>FDA Approves Vorasidenib for IDH-Mutant Gliomasѻýҕl> Treatment improved PFS by 16 months compared with placebo in INDIGO trial Aug 06, 2024
<ѻýҕl>Plant-based Food and Drink Labeling Is a Battlefieldѻýҕl> Public health considerations are missing in action Aug 06, 2024
<ѻýҕl>Prescription-Free Online Semaglutide Is Risky Businessѻýҕl> Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
<ѻýҕl>FDA Advisors Mostly Convinced Arimoclomol Works for Rare Genetic Disorderѻýҕl> If approved, this would be the first drug for Niemann-Pick disease type C Aug 03, 2024
<ѻýҕl>FDA Greenlights First Engineered Cell Therapy for a Solid Tumorѻýҕl> Afamitresgene autoleucel (Tecelra) approved for metastatic synovial sarcoma Aug 02, 2024
<ѻýҕl>FDA Panel to Consider Arimoclomol for Rare Genetic Disorderѻýҕl> This is the second time the drug has been submitted to the FDA for Niemann-Pick disease type C Aug 01, 2024